21 January 2016

Chairman's Share Purchase

David Evans, Chairman

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that David Evans, Chairman of the Company, has today purchased 1,000,000 ordinary shares in the Company at 7.5 pence per share.

Following this transaction, David Evans total beneficial holding has increased to 13,888,730 ordinary shares representing 8.1 per cent of the issued ordinary share capital of the Company.

David Evans, Non-Executive Chairman, commented: "As was announced in the recent trading update, I have purchased a further one million shares in Collagen Solutions which re-affirms my commitment to the Company and strong belief in the growth potential that the Company offers."

 

Enquiries:

Collagen Solutions Plc  
David Evans, Chairman Tel: 07740 084 452
Stewart White, CEO Tel: 0141 558 2008
   
Panmure Gordon & Co (Nominated Advisor and Broker)  
Robert Naylor (Corporate Finance) Tel: 020 7886 2714
Maisie Atkinson (Corporate Broking) Tel: 020 7886 2905
   
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Mike Wort Mob: 07900 608 002
Anna Dunphy Mob: 07876 741 001